|
|
|
|
|
Glyburide |
|
Glyburide |
|
10238-21-8 |
|
Usage: Used to treat type 2 diabetes. As of 2007, is one of the World Health Organization Pharmacopoeia of two oral hypoglycemic agents.
|
|
MF: C23H28ClN3O5S MW: 494.00 Packing detail: 25KG drum Content: 99% Physical Character: White crystalline powder. Melting point 168-173 ¡É. Insoluble in water,slightly soluble in ethanol acetone chloroform. Brief introduce: In 2003, America's most popular hypoglycemic agents. A recent survey listed in Table Minge benzene urea brain swelling by preventing the onset of improved animal models. Follow-up studyfound that not using glibenclamide compared with patients who have been taking glibenclamide in patients with type 2 diabetes onsetNIH ratio improved.
|
Industrial field |
pharmaceutical |
|
|
|
|
|
|
|
There are no existing companies to distribute selected chemical product |
|
|
|
|
|